@FierceBiotech: Protein-based nanofiber envisioned for use in delivering cardio, Alzheimer's drugs. Story | Follow @FierceBiotech
@JohnCFierce: Mersana does an ADC development deal with Endo--$270M in biobucks. Release | Follow @JohnCFierce
@RyanMFierce: Not surprised. Accelrys (software for drug discovery labs) barely topped analyst EPS estimates for 4Q '11. More | Follow @RyanMFierce
> Continuing to speak out on one of his favorite themes, Sanofi ($SNY) CEO Chris Viehbacher told a conference in Boston that he's particularly enthusiastic about striking up new collaborations with biotech companies as a way to drive innovation at the pharma giant. After scaling down internal R&D, Sanofi has been looking externally for new and better therapies in the biotech pipeline. Story
> GE Healthcare has acquired Xcellerex, a biopharmaceutical manufacturer with expertise in recombinant proteins, antibodies and vaccines. No financial terms were disclosed. Release
> New data demonstrates that two new hepatitis C drugs from Vertex Pharmaceuticals ($VTRX) and Merck ($MRK) are effective in patients who are also infected with HIV. The Vertex drug, telaprevir, proved superior. Story
> Argos Therapeutics has yanked its IPO, citing market conditions. MedCity News reports that Argos will have to find some other way to fund Phase III cancer studies. Report
> As part of the buyout deal with Amgen ($AMGN), Micromet CEO Christian Itin and the rest of the executive team have resigned and been replaced by Amgen execs. Story
Pharma News
@FiercePharma: GSK's 19%-owned Aspen Pharmacare grew first-half sales 31% as Asia-Pacific revenues triple--Reuters. Article | Follow @FiercePharma
> Pradaxa patient's death draws more scrutiny of bleeding risks. Story
> Whistleblower claims Takeda blunted Actos heart reports. News
Medical Device News
> Abbott, Merck keep companion Dx trend going with cancer test. Article
> Accelmed, Peregrine Ventures pump up NLT Spine's funding to $14.5M. News
> FDA warns Synthes facility over complaint handling procedures. More
> Roche tries to pressure Illumina to start talking. Item
Biomarkers News
> Biomarkers warn of kidney injury after heart surgery. Story
> Biomarkers expose child cancer treatment heart risk. Article
> Mitochondria changes could track Alzheimer's disease. More
> Urine test could point out colon cancers. Item
Drug Delivery News
> Conceal drug delivery tech to avoid immune system wrath. Story
> With J&J deal undone, Orexo revamps drug delivery tech development. More
> Tekmira seeks court's rejection of Alnylam drug delivery patent suit. Article
> Protein-based nanofiber envisioned for drug delivery use. Item
And Finally… Boston-based Akili Interactive, which is being incubated at PureTech, is developing new therapeutic video games. Report